Gene targeting approaches to complex genetic diseases: atherosclerosis and essential hypertension - PubMed (original) (raw)
Review
Gene targeting approaches to complex genetic diseases: atherosclerosis and essential hypertension
O Smithies et al. Proc Natl Acad Sci U S A. 1995.
Abstract
Gene targeting allows precise, predetermined changes to be made in a chosen gene in the mouse genome. To date, targeting has been used most often for generation of animals completely lacking the product of a gene of interest. The resulting "knockout" mice have confirmed some hypotheses, have upset others, but have rarely been uninformative. Models of several human genetic diseases have been produced by targeting--including Gaucher disease, cystic fibrosis, and the fragile X syndrome. These diseases are primarily determined by defects in single genes, and their modes of inheritance are well understood. When the disease under study has a complex etiology with multiple genetic and environmental components, the generation of animal models becomes more difficult but no less valuable. The problems associated with dissecting out the individual genetic factors also increases substantially and the distinction between causation and correlation is often difficult. To prove causation in a complex system requires rigorous adherence to the principle that the experiments must allow detection of the effects of changing only a single variable at one time. Gene targeting experiments, when properly designed, can test the effects of a precise genetic change completely free from the effects of differences in any other genes (linked or unlinked to the test gene). They therefore allow proofs of causation.
Similar articles
- Molecular genetic approach to the pathophysiology of cardiovascular disease.
Kurabayashi M, Yazaki Y. Kurabayashi M, et al. Int Angiol. 1996 Sep;15(3):187-94. Int Angiol. 1996. PMID: 8971574 Review. - Gene targeting approaches to analyzing hypertension.
Takahashi N, Smithies O. Takahashi N, et al. J Am Soc Nephrol. 1999 Jul;10(7):1598-605. doi: 10.1681/ASN.V1071598. J Am Soc Nephrol. 1999. PMID: 10405217 Review. - Animal models of human genetic diseases.
Smithies O. Smithies O. Trends Genet. 1993 Apr;9(4):112-6. doi: 10.1016/0168-9525(93)90204-u. Trends Genet. 1993. PMID: 8516844 Review. - Gene-environment interaction in hypertension, stroke and atherosclerosis in experimental models and supportive findings from a world-wide cross-sectional epidemiological survey: a WHO-cardiac study.
Yamori Y, Nara Y, Mizushima S, Murakami S, Ikeda K, Sawamura M, Nabika T, Horie R. Yamori Y, et al. Clin Exp Pharmacol Physiol Suppl. 1992;20:43-52. Clin Exp Pharmacol Physiol Suppl. 1992. PMID: 1446409 Review. - Use of transgenic and gene-targeted mice to model the genetic basis of hypertensive disorders.
Merrill DC, Granwehr BP, Davis DR, Sigmund CD. Merrill DC, et al. Proc Assoc Am Physicians. 1997 Nov;109(6):533-46. Proc Assoc Am Physicians. 1997. PMID: 9394415 Review.
Cited by
- Genetic Ablation and Guanylyl Cyclase/Natriuretic Peptide Receptor-A: Impact on the Pathophysiology of Cardiovascular Dysfunction.
Pandey KN. Pandey KN. Int J Mol Sci. 2019 Aug 14;20(16):3946. doi: 10.3390/ijms20163946. Int J Mol Sci. 2019. PMID: 31416126 Free PMC article. Review. - Molecular and genetic aspects of guanylyl cyclase natriuretic peptide receptor-A in regulation of blood pressure and renal function.
Pandey KN. Pandey KN. Physiol Genomics. 2018 Nov 1;50(11):913-928. doi: 10.1152/physiolgenomics.00083.2018. Epub 2018 Aug 31. Physiol Genomics. 2018. PMID: 30169131 Free PMC article. Review. - Heterozygous Pitx2 Null Mice Accurately Recapitulate the Ocular Features of Axenfeld-Rieger Syndrome and Congenital Glaucoma.
Chen L, Gage PJ. Chen L, et al. Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):5023-5030. doi: 10.1167/iovs.16-19700. Invest Ophthalmol Vis Sci. 2016. PMID: 27654429 Free PMC article. - Palmoplantar Keratoderma in Slurp2-Deficient Mice.
Allan CM, Procaccia S, Tran D, Tu Y, Barnes RH 2nd, Larsson M, Allan BB, Young LC, Hong C, Tontonoz P, Fong LG, Young SG, Beigneux AP. Allan CM, et al. J Invest Dermatol. 2016 Feb;136(2):436-443. doi: 10.1016/j.jid.2015.11.003. Epub 2015 Nov 18. J Invest Dermatol. 2016. PMID: 26967477 Free PMC article. - Functions of the cellular prion protein, the end of Moore's law, and Ockham's razor theory.
del Río JA, Gavín R. del Río JA, et al. Prion. 2016;10(1):25-40. doi: 10.1080/19336896.2015.1126038. Prion. 2016. PMID: 26890218 Free PMC article.
References
- Am J Med. 1977 May;62(5):707-14 - PubMed
- Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3521-5 - PubMed
- Cell. 1982 Aug;30(1):205-13 - PubMed
- Arteriosclerosis. 1983 Jan-Feb;3(1):87-101 - PubMed
- EMBO J. 1982;1(11):1417-21 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical